263 related articles for article (PubMed ID: 17449900)
21. Is there an anti-fat bias among schizophrenia patients?
Pierson KE
Obesity (Silver Spring); 2006 Dec; 14(12):2305. PubMed ID: 17189559
[No Abstract] [Full Text] [Related]
22. [Atypical antipsychotic induced weight gain and metabolic disorders].
Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C
Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331
[TBL] [Abstract][Full Text] [Related]
23. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
24. Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.
Weiden PJ
J Clin Psychiatry; 2007; 68 Suppl 4():34-9. PubMed ID: 17539698
[TBL] [Abstract][Full Text] [Related]
25. When essential medications provoke new health problems: the metabolic effects of second-generation antipsychotics.
Stein K
J Am Diet Assoc; 2010 Jul; 110(7):992-1001. PubMed ID: 20630154
[No Abstract] [Full Text] [Related]
26. Obesity in schizophrenia: screening, monitoring, and health promotion.
Beebe LH
Perspect Psychiatr Care; 2008 Jan; 44(1):25-31. PubMed ID: 18177275
[TBL] [Abstract][Full Text] [Related]
27. Medication-induced weight gain and dyslipidemia in patients with schizophrenia.
Fenton WS; Chavez MR
Am J Psychiatry; 2006 Oct; 163(10):1697-704; quiz 1858-9. PubMed ID: 17012676
[No Abstract] [Full Text] [Related]
28. [Non-pharmacological interventions for weight gain in patients with schizophrenia taking antipsychotics].
Attux C; Martini LC; Reis AF; Bressan RA
Arq Bras Endocrinol Metabol; 2009 Jun; 53(4):391-8. PubMed ID: 19649375
[TBL] [Abstract][Full Text] [Related]
29. Weight gain and first-generation antipsychotics: experience from a developing country.
Yoon CK
J Clin Psychopharmacol; 2008 Oct; 28(5):574-6. PubMed ID: 18794660
[No Abstract] [Full Text] [Related]
30. Schizophrenia and weight management: a systematic review of interventions to control weight.
Faulkner G; Soundy AA; Lloyd K
Acta Psychiatr Scand; 2003 Nov; 108(5):324-32. PubMed ID: 14531752
[TBL] [Abstract][Full Text] [Related]
31. [Atypical antipsychotic-induced weight gain].
Godlewska BR; Olajossy-Hilkesberger L; Marmurowska-Michałowska H; Olajossy M; Landowski J
Psychiatr Pol; 2006; 40(5):995-1007. PubMed ID: 17217241
[TBL] [Abstract][Full Text] [Related]
32. [Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study].
Diurni M; Baranzini F; Costantini C; Poloni N; Vender S; Callegari C
Recenti Prog Med; 2009 Feb; 100(2):103. PubMed ID: 19350804
[No Abstract] [Full Text] [Related]
33. Gaining: pediatric patients and use of atypical antipsychotics.
Towbin KE
Am J Psychiatry; 2006 Dec; 163(12):2034-6. PubMed ID: 17151148
[No Abstract] [Full Text] [Related]
34. [Schizophrenia, obesity and pharmacotherapy-associated weight gain].
Carpiniello B; Corda E; Maccioni R; Pinna F
Clin Ter; 2008; 159(5):299-306. PubMed ID: 18998030
[TBL] [Abstract][Full Text] [Related]
35. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
Miller LJ
Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
[TBL] [Abstract][Full Text] [Related]
36. How to manage in current treatment of schizophrenic patients.
Loga S
Psychiatr Danub; 2007 Dec; 19(4):359-61. PubMed ID: 18000489
[TBL] [Abstract][Full Text] [Related]
37. Obesity in schizophrenia: what can be done about it?
Catapano L; Castle D
Australas Psychiatry; 2004 Mar; 12(1):23-5. PubMed ID: 15715734
[TBL] [Abstract][Full Text] [Related]
38. Weight gain with atypical antipsychotics: evidence and insights.
Henderson DC
J Clin Psychiatry; 2007; 68 Suppl 12():18-26. PubMed ID: 17956152
[TBL] [Abstract][Full Text] [Related]
39. When the heart and the mind collide: cardiovascular risk factors and antipsychotic use in the schizophrenic population.
Halpert S; McFarlane SI
J Cardiometab Syndr; 2009; 4(1):1-5. PubMed ID: 19245509
[No Abstract] [Full Text] [Related]
40. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
Le Hellard S; Theisen FM; Haberhausen M; Raeder MB; Fernø J; Gebhardt S; Hinney A; Remschmidt H; Krieg JC; Mehler-Wex C; Nöthen MM; Hebebrand J; Steen VM
Mol Psychiatry; 2009 Mar; 14(3):308-17. PubMed ID: 18195716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
